Foresite Capital Management VI’s Kymera Therapeutics KYMR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$6.39M Hold
146,332
3.59% 10
2025
Q1
$4.01M Hold
146,332
2.19% 12
2024
Q4
$5.89M Buy
+146,332
New +$5.89M 2.62% 12